1. Home
  2. SPCB vs GDTC Comparison

SPCB vs GDTC Comparison

Compare SPCB & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$8.90

Market Cap

43.8M

Sector

Technology

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.59

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
GDTC
Founded
1988
2018
Country
Israel
Singapore
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
24.8M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
SPCB
GDTC
Price
$8.90
$1.59
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
92.5K
79.1K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$26,739,000.00
$573,193.00
Revenue This Year
N/A
$5.37
Revenue Next Year
$27.13
N/A
P/E Ratio
$11.12
N/A
Revenue Growth
N/A
63.03
52 Week Low
$3.14
$1.50
52 Week High
$18.95
$4.05

Technical Indicators

Market Signals
Indicator
SPCB
GDTC
Relative Strength Index (RSI) 43.64 39.16
Support Level $8.64 $1.71
Resistance Level $9.92 $1.68
Average True Range (ATR) 0.49 0.12
MACD 0.04 -0.01
Stochastic Oscillator 28.62 19.35

Price Performance

Historical Comparison
SPCB
GDTC

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: